MedTrace Logo

Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients

NCT04649840 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2021-12-10

No results posted yet for this study

Summary

The goal of the project: to study the dynamics of the humoral and cellular immunity in patients after pneumonia caused by the SARS-CoV-2 virus at different time intervals, in order to predict the duration of immune protection

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Humoral and cellular immunity

Humoral (IgG) and cellular (antigen-specific cells) immunity

Sponsors & Collaborators

  • Belarusian State Medical University

    collaborator OTHER

  • The Republican Research and Practical Center for Epidemiology and Microbiology

    collaborator OTHER

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Andrei Hancharou, MD, PHD · Director

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-12-09
Completion
2021-12-09

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04649840 on ClinicalTrials.gov